Medindia LOGIN REGISTER
Medindia
Advertisement

Symmetry Medical Extends 10-K Filing Beyond April 14, 2008 Target

Tuesday, April 15, 2008 General News
Advertisement
WARSAW, Ind., April 14 Symmetry Medical Inc.(NYSE: SMA), a leading independent provider of products to the globalorthopedic device industry and other medical markets, today announced that thefiling of its 2007 Annual Report on Form 10-K with the Securities and ExchangeCommission will be delayed beyond its previously announced April 14, 2008target. The filing is now in the final stages and the work is substantiallycompleted. The Company said the focus is now on formatting the data,completing the financial statements and preparing the filings.
Advertisement

Symmetry has informed its lead bank of the filing timing change andexpects to continue discussions with the bank over the next few days as thefilings are finalized.
Advertisement

Brian Moore, President and Chief Executive Officer, said, "We are workingdiligently with our outside auditing team to file our 2007 Form 10-K as soonas possible. This has been an extremely challenging and time consumingprocess for management and the audit committee. We believe we are coming tothe finalization of the process. Meanwhile, the Company's business continuesstrong in an orthopedic environment that we believe will result in a robustyear for Symmetry's business."

About Symmetry Medical Inc.

Symmetry Medical Inc. is a leading independent provider of implants andrelated instruments and cases to the orthopedic device industry. The Companyalso designs, develops and produces these products for companies in othersegments of the medical device market, including arthroscopy, dental,laparoscopy, osteobiologic and endoscopy sectors and provides limitedspecialized products and services to non-healthcare markets, such as theaerospace market.

Forward-Looking Statements

Statements in the press release regarding Symmetry Medical Inc.'s businessand regarding our Audit Committee's investigation and related restatement,which are not historical facts, may be "forward-looking statements" thatinvolve risks and uncertainties, within the safe harbor provisions of thePrivate Securities Litigation Reform Act of 1995. Forward-looking statementsare predictive in nature and are frequently identified by the use of termssuch as "may," "might," "will," "should," "expect," "believe," "anticipate,""plan," "estimate," "intend," and similar words indicating possible futureexpectations, events or actions. Such predictive statements are not guaranteesof future performance, and actual outcomes and results could differ materiallyfrom our current expectations. Certain factors that could cause actual resultsto differ include: the loss of one or more customers; the development of newproducts or product innovations by our competitors; product liability; changesin management; changes in conditions effecting the economy, orthopedic devicemanufacturers or the medical device industry generally; and changes ingovernment regulation of medical devices and third-party reimbursementpractices. We refer you to the "Risk Factors" and "Forward Looking Statements"sections in the Company's most recent Annual Report on Form 10-K filed withthe Securities and Exchange Commission as well as the Company's other filingswith the SEC, which are available on the SEC's Web site at www.sec.gov.Investors/Media: Contact: The Ruth Group Symmetry Medical Inc. Nick Laudico/Jason Rando Fred L. Hite (646) 536-7030/7025 Senior Vice President [email protected] Chief Financial Officer [email protected] (574) 371-2218

SOURCE Symmetry Medical Inc.
Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close